taurine has been researched along with Psychotic Disorders in 5 studies
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine is an inhibitory neuromodulatory amino acid in the central nervous system that activates the GABA- and glycine-insensitive chloride channel and inhibits the N-methyl-D-aspartate receptor." | 2.82 | Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study. ( Allott, KA; McGorry, PD; Moral, J; Murphy, BP; O'Donnell, CP; O'Regan, MK; Papas, A; Pham, T; Phassouliotis, C; Proffitt, TM; Simpson, R; Yuen, HP, 2016) |
| "Taurine is a naturally occurring essential β-amino acid reported to elicit antipsychotic property in first episode psychosis in clinical setting, thus require preclinical investigation." | 1.72 | Taurine, an essential β-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative/nitrergic imbalances, and suppression of COX-2/iNOS immunoreactions in mice. ( Adebayo, OG; Ben-Azu, B; Chijioke, BS; Edje, KE; Eduviere, AT; Esuku, DT; Japhet, K; Jarikre, TA; Moke, EG; Odili, OS; Omogbiya, IA; Omondiabge, OP; Oyovbaire, A; Oyovwi, MO; Ozah, EO, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Azu, B | 1 |
| Adebayo, OG | 1 |
| Jarikre, TA | 1 |
| Oyovwi, MO | 1 |
| Edje, KE | 1 |
| Omogbiya, IA | 1 |
| Eduviere, AT | 1 |
| Moke, EG | 1 |
| Chijioke, BS | 1 |
| Odili, OS | 1 |
| Omondiabge, OP | 1 |
| Oyovbaire, A | 1 |
| Esuku, DT | 1 |
| Ozah, EO | 1 |
| Japhet, K | 1 |
| O'Donnell, CP | 1 |
| Allott, KA | 1 |
| Murphy, BP | 1 |
| Yuen, HP | 1 |
| Proffitt, TM | 1 |
| Papas, A | 1 |
| Moral, J | 1 |
| Pham, T | 1 |
| O'Regan, MK | 1 |
| Phassouliotis, C | 1 |
| Simpson, R | 1 |
| McGorry, PD | 1 |
| Verhoeven, WM | 1 |
| Van Ravenswaaij-Arts, CM | 1 |
| De Leeuw, N | 1 |
| Fekkes, D | 3 |
| Van der Heijden, FM | 1 |
| Egger, JI | 1 |
| Tuinier, S | 1 |
| Pepplinkhuizen, L | 2 |
| Verheij, R | 1 |
| Bruinvels, J | 1 |
| Bode, WT | 1 |
| Zijlstra, FJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment.[NCT00420823] | Phase 2/Phase 3 | 121 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for taurine and Psychotic Disorders
| Article | Year |
|---|---|
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognitive Dysfunction; Double-Blind Method; Drug Therapy, C | 2016 |
4 other studies available for taurine and Psychotic Disorders
| Article | Year |
|---|---|
Taurine, an essential β-amino acid insulates against ketamine-induced experimental psychosis by enhancement of cholinergic neurotransmission, inhibition of oxidative/nitrergic imbalances, and suppression of COX-2/iNOS immunoreactions in mice.
Topics: Acetylcholinesterase; Amino Acids; Animals; Cholinergic Agents; Cyclooxygenase 2; Ketamine; Male; Mi | 2022 |
Disturbed serine metabolism and psychosis in a patient with a de novo translocation (2;10)(p23;q22.1).
Topics: Adult; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 2; DiGeorge Syndrome; Female; Humans; H | 2006 |
Abnormal plasma levels of serine, methionine, and taurine in transient acute polymorphic psychosis.
Topics: Adult; Bipolar Disorder; Diagnosis, Differential; Female; Humans; Male; Methionine; Middle Aged; Psy | 1994 |
Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms.
Topics: Adult; Female; Glutathione; Humans; Male; Methionine; Prostaglandins E; Psychotic Disorders; Serine; | 1996 |